OVX033
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OVX033, covering 2025-03-24 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers [Phase 1]